DATED 4th November 2015 (“Agreement Date”)Collaboration Agreement • March 30th, 2016 • AmpliPhi Biosciences Corp • Biological products, (no disgnostic substances) • England and Wales
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 30th, 2016 • AmpliPhi Biosciences Corp • Biological products, (no disgnostic substances)
THIS ASSET PURCHASE AGREEMENT (this “Agreement”) is entered into as of January 4, 2016, by and among (i) AmpliPhi Biosciences Corporation, a Washington corporation (the “Purchaser”) and (ii) Novolytics Limited, a company organized under the laws of England and Wales (the “Company”). The Purchaser and the Company may be referred to herein individually as a “Party” and collectively as the “Parties.”
WARRANT TO PURCHASE SHARES OF COMMON STOCK OF AMPLIPHI BIOSCIENCES CORPORATIONWarrant Agreement • March 30th, 2016 • AmpliPhi Biosciences Corp • Biological products, (no disgnostic substances) • California
THIS IS TO CERTIFY THAT, FOR VALUE RECEIVED, [_______________], a [_______________] (“Holder”), is entitled, subject to the terms set forth below, to purchase from AmpliPhi Biosciences Corporation, a Washington corporation (the “Company”), [__________]1 shares of the Company’s Common Stock, USD$0.01 par value per share (the “Common Stock”), subject to adjustment as provided in Section 9 (the “Warrant Shares”), at the Purchase Price set forth in Section 3.
